Olivier Glehen

7PUBLICATIONS
27CO-AUTHORS
Major global burdens of diseaseMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 27, 2025
Pulmonary Emphysema: Current Understanding of Disease Pathogenesis and Therapeutic Approaches.

Abderrazzak Bentaher, Olivier Glehen, Ghania Degobert

|Sep 23, 2025
Pathogen Enzyme-Mediated Alkoxyamine Homolysis as a Killing Mechanism of <i>Aspergillus fumigatus</i>.

Marion Filliâtre, Pierre Voisin, Seda Seren

|May 31, 2024
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort.

Pauline Corbaux, Gilles Freyer, Olivier Glehen

|Sep 07, 2022
Advances in the management of peritoneal malignancies.

Vahan Kepenekian, Aditi Bhatt, Julien Péron

|Jan 11, 2022
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL).

Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas

Pageof 2